Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SENDO Foundation (Southern Europe New Drugs Organization) is an independent, non-profit clinical research organization based in Milan, Italy, specializing in the development of early-phase clinical trials for innovative anticancer agents. Established in 1998, the foundation acts as a strategic bridge between preclinical laboratory research and clinical application, primarily coordinating Phase I and early Phase II oncology studies. It provides comprehensive services including protocol design, regulatory management, and trial monitoring through a network of European centers of excellence. SENDO collaborates extensively with both academic institutions and the pharmaceutical industry to accelerate the delivery of new therapeutic options to cancer patients. The organization is also dedicated to professional training and the optimization of clinical trial methodology in the field of oncology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SENDO Foundation.